SourceOne Stock Info  Your one source site for stock research




Company Website

Investor Relations



What’s the buzz—

message boards


Market Watch

Money Central

Raging Bull

Board Central









Par Pharmaceutical



Par Pharmaceutical is a holding company that, mostly through its wholly owned subsidiary, Par Pharmaceutical, Inc., is in the business of developing, manufacturing and distributing generic and branded drugs in the United States. During the year ended December 2006, the Company announced its divestiture of FineTech Laboratories, Ltd. As a result of the divestiture, the business is being reported as a discontinued operation for all periods presented, as applicable. The company distributes approximately 80 products, representing various dosage strengths for 40 separate drugs that are manufactured by the company and 100 additional products, representing various dosage strengths for 41 separate drugs that are manufactured for it by other companies. Par Pharmaceutical holds the Abbreviated New Drug Applications and New Drug Applications for the drugs that it manufactures.


Stock Quotes and Other Information





Silicon Investor



Market Watch

Clear Station



SourceOne Message Board


Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name














S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35